RBR-6wg54rbActive, not recruitingPhase 3
Sleep Duration Variability: a Therapeutic Target of Melatonin for Glycemic Control in patients with Type 2 Diabetes Mellitus
niversidade Federal de Minas Gerais0 sitesStarted: February 22, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 40Y to 0 (—)
Inclusion Criteria
- •This project will include patients diagnosed with diabetes mellitus type 2 for more than one year; age greater than or equal to 40 years; family history of diabetes mellitus type 2; glycosylated haemoglobin between 7 and 10%
Exclusion Criteria
- •Pregnancy; corticosteroids use within less than 3 months; or other medications that elevate glycemia; diseases that significantly alter glycemia stability (renal failure, acute coronary syndrome, cancer, liver failure, among others); uncontrolled diabetes, with polydipsia, polyuria, or weight loss requiring insulin or other drugs; high risk for severe sleep apnea; depression; shift work; epilepsy; refusal to participate in this research at any time
Investigators
Similar Trials
Completed
Not Applicable
Performance, Mood, and Brain and Metabolic Functions During Different Sleep SchedulesSleepSleep RestrictionNCT04731662National University of Singapore59
Completed
Not Applicable
Circadian Regulation of Sleep in Habitual Short Sleepers and Long SleepersSleep DisordersNCT00001546National Institute of Mental Health (NIMH)38
Completed
Not Applicable
Daily variation in sleep apnea status and atrial fibrillation.Sleep ApneaAtrial FibrillationACTRN12618000757213Center for Heart Rhythm Disorders.72
Completed
Not Applicable
The Effects of Sleep Variability in YouthSleep VariabilityNCT04263428The University of Hong Kong41
Completed
Not Applicable
ight treatment for sleep and circadian disruption in kidney donor patientssleep disruption following surgeryNeurological - Studies of the normal brain and nervous systemACTRN12614000494639niversity of Auckland40